Short answer · Medically reviewed summary · Last updated: 2026-05-08
Melanoma is a common form of skin cancer with an estimated global incidence of over 325,000 new cases annually, though its prevalence varies significantly based on UV exposure and genetic factors. While not classified as a rare disease globally, certain rare subtypes—such as ocular or mucosal melanoma—are considered rare and require specialized care. Is melanoma considered a rare disease? In most Western populations, cutaneous melanoma is considered a common malignancy rather than a rare disease.
What is the prevalence of Melanoma?
Prevalence of Melanoma: how many people are affected worldwide, differences by sex and region, with sources.
Melanoma is a common form of skin cancer with an estimated global incidence of over 325,000 new cases annually, though its prevalence varies significantly based on UV exposure and genetic factors. While not classified as a rare disease globally, certain rare subtypes—such as ocular or mucosal melanoma—are considered rare and require specialized care.
Is melanoma considered a rare disease?
In most Western populations, cutaneous melanoma is considered a common malignancy rather than a rare disease. However, the term melanoma encompasses several distinct biological variants. While cutaneous melanoma accounts for the vast majority of cases, rare forms like mucosal, uveal, and acral lentiginous melanoma have low incidence rates and are often managed as rare conditions. It is important to note that true global prevalence is difficult to capture due to variations in cancer registry reporting and potential underdiagnosis of early-stage lesions.
How does melanoma incidence vary by demographics?
The epidemiology of melanoma shows clear patterns regarding age, gender, and geography:
- Age of Onset: While melanoma is primarily diagnosed in adults (median age at diagnosis is approximately 65), it can occur in young adults and, rarely, in pediatric populations.
- Gender Distribution: Men are statistically more likely to develop melanoma and experience higher mortality rates, though incidence rates are rising in both sexes.
- Geographic/Ethnic Factors: Prevalence is highest in populations with fair skin living in high-UV index regions, such as Australia, New Zealand, and parts of North America and Northern Europe.
What challenges exist in measuring melanoma prevalence?
Accurate statistics for melanoma are often hampered by inconsistencies in how local health systems track skin cancers. Many registry databases exclude non-invasive (in situ) melanoma, which can lead to a significant underestimation of the actual disease burden. Furthermore, misdiagnosis of pigmented lesions can lead to delays in reporting, meaning current data should be viewed as an estimate rather than an exact census.
At DiseaseMaps.org, we have 30 community members currently sharing their experiences with melanoma. This real-world, patient-centered data complements clinical statistics by highlighting the lived reality of navigating diagnosis and treatment pathways.
Next steps
- Schedule an annual full-body skin examination with a board-certified dermatologist.
- Monitor your skin for changes using the ABCDE rule (Asymmetry, Border, Color, Diameter, Evolving).
- Join the DiseaseMaps.org community to connect with others and share your journey.
- Consult a clinical geneticist if you have a strong family history of melanoma.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.
References
- World Health Organization (WHO) - GLOBOCAN Database
- American Cancer Society (ACS) - Cancer Facts & Figures
- National Cancer Institute (NCI) - SEER Program
- Orphanet - Rare Disease Database (for rare melanoma subtypes)
